Controversies in the Treatment of Lymphoma with Autologous Transplantation

Por Moskowitz, Alison J., Moskowitz, Craig H.
Publicado em 2009

Excellent Outcomes and Lack of Prognostic Impact of Cell of Origin for Localized Diffuse Large B-cell Lymphoma in the Rituximab Era

Por Kumar, Anita, Lunning, Matthew A., Zhang, Zhigang, Migliacci, Jocelyn C., Moskowitz, Craig H., Zelenetz, Andrew D.
Publicado no Br J Haematol (2015)

Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma

Por Moskowitz, Alison J., Yahalom, Joachim, Kewalramani, Tarun, Maragulia, Jocelyn C., Vanak, Jill M., Zelenetz, Andrew D., Moskowitz, Craig H.
Publicado em 2010

Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma

Por Ulaner, Gary A., Goldman, Debra A., Sauter, Craig S., Migliacci, Jocelyn, Lilienstein, Joshua, Gönen, Mithat, Schöder, Heiko, Moskowitz, Craig H., Zelenetz, Andrew D.
Publicado no Radiology (2015)

Outcomes for Patients Who Fail High Dose Chemoradiotherapy and Autologous Stem Cell Rescue for Relapsed and Primary Refractory Hodgkin Lymphoma

Por Moskowitz, Alison J, Perales, Miguel-Angel, Kewalramani, Tarun, Yahalom, Joachim, Castro-Malaspina, Hugo, Zhang, Zhigang, Vanak, Jill, Zelenetz, Andrew D, Moskowitz, Craig H
Publicado em 2009

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013

Por Ribrag, Vincent, Armand, Phillippe, Kuruvilla, John, Michot, Jean-Marie, Moskowitz, Craig H, Marinello, Patricia, Snyder, Ellen, Balakumaran, Arun, Shipp, Margaret A, Zinzani, Pier Luigi
Publicado no J Immunother Cancer (2015)

Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma

Por Sauter, Craig S., Matasar, Matthew J., Meikle, Jessica, Schoder, Heiko, Ulaner, Gary A., Migliacci, Jocelyn C., Hilden, Patrick, Devlin, Sean M., Zelenetz, Andrew D., Moskowitz, Craig H.
Publicado no Blood (2015)

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087

Por Chen, Robert, Armand, Phillippe, Fanale, Michelle A, Ribrag, Vincent, Zinzani, Pier Luigi, Ricart, Alejandro D, Thompson, Seth, Balakumaran, Arun, Molin, Daniel, Shipp, Margaret A, Moskowitz, Craig H
Publicado no J Immunother Cancer (2015)

The Potential Benefit of Allogeneic over Autologous Transplantation in Patients with Very Early Relapsed and Refractory Follicular Lymphoma with Prior Remission Duration of ≤ 12 Mo...

Por Lunning, Matthew A., Migliacci, Jocelyn C., Hilden, Patrick, Devlin, Sean M., Castro-Malaspina, Hugo, Giralt, Sergio, Perales, Miguel-Angel, Zelenetz, Andrew D., Moskowitz, Craig H., Sauter, Craig S.
Publicado no Br J Haematol (2016)

Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transpl...

Por Vose, Julie M., Carter, Shelly, Burns, Linda J., Ayala, Ernesto, Press, Oliver W., Moskowitz, Craig H., Stadtmauer, Edward A., Mineshi, Shin, Ambinder, Richard, Fenske, Timothy, Horowitz, Mary, Fisher, Richard, Tomblyn, Marcie
Publicado em 2013

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Por Gisselbrecht, Christian, Glass, Bertram, Mounier, Nicolas, Singh Gill, Devinder, Linch, David C., Trneny, Marek, Bosly, Andre, Ketterer, Nicolas, Shpilberg, Ofer, Hagberg, Hans, Ma, David, Brière, Josette, Moskowitz, Craig H., Schmitz, Norbert
Publicado em 2010

Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes

Por Kumar, Anita, Burger, Irene A., Zhang, Zhigang, Drill, Esther N., Migliacci, Jocelyn C., Ng, Andrea, LaCasce, Ann, Wall, Darci, Witzig, Thomas E., Ristow, Kay, Yahalom, Joachim, Moskowitz, Craig H., Zelenetz, Andrew D.
Publicado no Haematologica (2016)

Prospective Study of FLT PET for Early Interim Response Assessment in Advanced Stage B-cell Lymphoma

Por Schöder, Heiko, Zelenetz, Andrew D., Hamlin, Paul, Gavane, Somali, Horwitz, Steven, Matasar, Matthew, Moskowitz, Alison, Noy, Ariela, Palomba, Lia, Portlock, Carol, Straus, David, Grewal, Ravinder, Migliacci, Jocelyn C., Larson, Steven M., Moskowitz, Craig H.
Publicado no J Nucl Med (2015)

Phase II Study of Bendamustine in Relapsed and Refractory Hodgkin Lymphoma

Por Moskowitz, Alison J., Hamlin, Paul A., Perales, Miguel-Angel, Gerecitano, John, Horwitz, Steven M., Matasar, Matthew J., Noy, Ariela, Palomba, Maria Lia, Portlock, Carol S., Straus, David J., Graustein, Tricia, Zelenetz, Andrew D., Moskowitz, Craig H.
Publicado em 2013

Effectiveness of Partner Social Support Predicts Enduring Psychological Distress after Hematopoietic Stem Cell Transplantation

Por Rini, Christine, Redd, William H., Austin, Jane, Mosher, Catherine E., Meschian, Yeraz Markarian, Isola, Luis, Scigliano, Eileen, Moskowitz, Craig H., Papadopoulos, Esperanza, Labay, Larissa E., Rowley, Scott, Burkhalter, Jack E., Schetter, Christine Dunkel, DuHamel, Katherine N.
Publicado em 2011

Normalization of pre-ASCT, FDG-PET imaging with second-line, non–cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma

Por Moskowitz, Craig H., Matasar, Matt J., Zelenetz, Andrew D., Nimer, Stephen D., Gerecitano, John, Hamlin, Paul, Horwitz, Steven, Moskowitz, Alison J., Noy, Ariela, Palomba, Lia, Perales, Miguel-Angel, Portlock, Carol, Straus, David, Maragulia, Jocelyn C., Schoder, Heiko, Yahalom, Joachim
Publicado em 2012

R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma

Por Omuro, Antonio, Correa, Denise D., DeAngelis, Lisa M., Moskowitz, Craig H., Matasar, Matthew J., Kaley, Thomas J., Gavrilovic, Igor T., Nolan, Craig, Pentsova, Elena, Grommes, Christian C., Panageas, Katherine S., Baser, Raymond E., Faivre, Geraldine, Abrey, Lauren E., Sauter, Craig S.
Publicado no Blood (2015)

A Phase 2 Study of a Non-myeloablative Allogeneic Stem Cell Transplant with Peri-transplant Rituximab in Patients with B-cell Lymphoid Malignancies: Favorably Durable Event-free Su...

Por Sauter, Craig S., Barker, Juliet N., Lechner, Lauren, Zheng, Junting, Devlin, Sean M., Papadopoulos, Esperanza B., Perales, Miguel-Angel, Jakubowski, Ann A., Goldberg, Jenna D., Koehne, Guenther, Ceberio, Izaskun, Giralt, Sergio, Zelenetz, Andrew D., Moskowitz, Craig H., Castro-Malaspina, Hugo
Publicado no Biol Blood Marrow Transplant (2013)

Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma...

Por O'Connor, Owen A., Horwitz, Steven, Hamlin, Paul, Portlock, Carol, Moskowitz, Craig H., Sarasohn, Debra, Neylon, Ellen, Mastrella, Jill, Hamelers, Rachel, MacGregor-Cortelli, Barbara, Patterson, Molly, Seshan, Venkatraman E., Sirotnak, Frank, Fleisher, Martin, Mould, Diane R., Saunders, Mike, Zelenetz, Andrew D.
Publicado em 2009

Rituximab Maintenance Therapy After Autologous Stem-Cell Transplantation in Patients With Relapsed CD20(+) Diffuse Large B-Cell Lymphoma: Final Analysis of the Collaborative Trial...

Por Gisselbrecht, Christian, Schmitz, Norbert, Mounier, Nicolas, Singh Gill, Devinder, Linch, David C., Trneny, Marek, Bosly, Andre, Milpied, Noel J., Radford, John, Ketterer, Nicolas, Shpilberg, Ofer, Dührsen, Ulrich, Hagberg, Hans, Ma, David D., Viardot, Andreas, Lowenthal, Ray, Brière, Josette, Salles, Gilles, Moskowitz, Craig H., Glass, Bertram
Publicado em 2012